Home › Drug Codes › Q Codes › Q5139 · BKEMV
Updated July 1st, 2026

BKEMV Q Code: Q5139

Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
—
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg
HCPCS Added Date January 1, 2025
Manufacturer Amgen Inc
Generic Status HCPCS Discontinued

About BKEMV

Bkemv is a medication aligned to the HCPCS Q Code: Q5139 for billing, pricing, and reimbursement purposes in the United States. It is a Hematology drug manufactured by Amgen Inc.

Manufacturers, reach out to us to add more information.

NDC Code Information

No NDC packages are aligned to Q5139 in publicly available CMS files.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
No public NDC alignments
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

Biosimilar Information

BKEMV Approval Date: May 28, 2024

Product Name HCPCS Code Active Ingredient BLA Type
Soliris J1299 Eculizumab 351(a) Originator Product
Bkemv Q5139 Eculizumab 351(k) Interchangeable
Epysqli Q5151 Eculizumab 351(k) Interchangeable

BKEMV CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

BKEMV Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Paroxysmal Nocturnal Hemoglobinuria (PNH) Atypical Hemolytic Uremic Syndrome (aHUS) Generalized Myasthenia Gravis (gMG)

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available BKEMV billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for BKEMV
What are the available BKEMV patient assistance programs?
Our team has not identified a source of patient assistance information for BKEMV
Where can I find BKEMV prescribing information?
BKEMV prescribing information can be found at the link below. Visit Here →
Where can I find BKEMV side effect information?
BKEMV side effect information can be found through MedlinePlus at the link below.
Does billing BKEMV require JZ/JW wastage modifiers?
CMS does not include BKEMV (Q5139) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q5139. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.